Traverse Vascular Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Traverse Vascular General Information
Description
Developer of a next-generation microcatheter designed to help in chronic total occlusions in the coronary and peripheral vasculature. The company's product addresses procedural shortcomings in subintimal hematoma removal and better catheter positioning whilst being hydrophilic coated to ensure smooth delivery, enabling physicians to improve visualization, enhanced access to true lumen target and precise turn-for-turn response.
Contact Information
Corporate Office
- 535 Stevens Avenue West
- Solana Beach, CA 92075
- United States
Corporate Office
- 535 Stevens Avenue West
- Solana Beach, CA 92075
- United States
Traverse Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 13-Jun-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 20-Aug-2021 | Completed | Startup | |||
| 1. Angel (individual) | 31-Dec-2019 | $800K | $800K | Completed | Startup |
Traverse Vascular Comparisons
Industry
Financing
Details
Traverse Vascular Competitors (3)
One of Traverse Vascular’s 3 competitors is Medtronic, a Corporation company based in Minneapolis, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medtronic | Corporation | Minneapolis, MN | ||||
| Teleflex | Corporation | Wayne, PA | ||||
| Asahi Intecc | Formerly VC-backed | Seto, Japan |
Traverse Vascular Patents
Traverse Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11369392-B2 | Intravascular catheter with fluoroscopically visible indicium of rotational orientation | Active | 05-Apr-2019 | ||
| US-20200330731-A1 | Intravascular catheter with fluoroscopically visible indicium of rotational orientation | Active | 05-Apr-2019 | ||
| US-11154312-B2 | Reentry catheter for crossing a vascular occlusion | Active | 05-Apr-2019 | ||
| US-12035930-B2 | Reentry catheter for crossing a vascular occlusion | Active | 05-Apr-2019 | ||
| US-20200330111-A1 | Reentry catheter for crossing a vascular occlusion | Active | 05-Apr-2019 | A61B17/22 |
Traverse Vascular Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority |
Traverse Vascular FAQs
-
When was Traverse Vascular founded?
Traverse Vascular was founded in 2018.
-
Where is Traverse Vascular headquartered?
Traverse Vascular is headquartered in Solana Beach, CA.
-
What industry is Traverse Vascular in?
Traverse Vascular’s primary industry is Therapeutic Devices.
-
Is Traverse Vascular a private or public company?
Traverse Vascular is a Private company.
-
What is Traverse Vascular’s current revenue?
The current revenue for Traverse Vascular is .
-
How much funding has Traverse Vascular raised over time?
Traverse Vascular has raised $1.86M.
-
Who are Traverse Vascular’s investors?
has invested in Traverse Vascular.
-
Who are Traverse Vascular’s competitors?
Medtronic, Teleflex, and Asahi Intecc are competitors of Traverse Vascular.
-
When was Traverse Vascular acquired?
Traverse Vascular was acquired on 13-Jun-2022.
-
Who acquired Traverse Vascular?
Traverse Vascular was acquired by Teleflex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process